Literature DB >> 75485

Non-appearance of injected fibroblast interferon in circulation.

V G Edy, A Billiau, P De Somer.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 75485     DOI： 10.1016/s0140-6736(78)91251-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, double-blind, randomized study.

Authors:  E Villa; P Trande; A Grottola; P Buttafoco; A M Rebecchi; T Stroffolini; F Callea; A Merighi; L Camellini; P Zoboli; R Cosenza; L Miglioli; P Loria; R Iori; N Carulli; F Manenti
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 2.  Antiviral agents: action and clinical use.

Authors:  T W Chang; D R Snydman
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

3.  Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle.

Authors:  E C Short; R W Fulton
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

4.  Spontaneous production of human interferon.

Authors:  L A Pickering; L H Kronenberg; W E Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

Review 5.  Differences between human alpha (leukocyte) and beta (fibroblast) interferons.

Authors:  T G Hayes
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 6.  Interferon therapy: pharmacokinetic and pharmacological aspects.

Authors:  A Billiau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

7.  Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.

Authors:  A Billiau; H Heremans; D Ververken; J van Damme; H Carton; P de Somer
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

8.  Deficient natural killer cell activity in a patient with Fanconi's anaemia and squamous cell carcinoma. Association with defect in interferon release.

Authors:  P Hersey; A Edwards; R Lewis; A Kemp; J McInnes
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

9.  Attempted treatment of fulminant viral hepatitis with human fibroblast interferon.

Authors:  F Milazzo; M Galli; P G Fassio; A Cargnel; A Pugliese; P A Tovo; G M Vigevani; R Esposito; A Lazzarin; F Caredda
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

10.  Assessment of the antigenic response in humans to a recombinant mutant interferon beta.

Authors:  M W Konrad; A L Childs; T C Merigan; E C Borden
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.